norm: impact biomedicalNAICS Pharmaceutical Preparations · USno LEI · CIK 0001834105Max severity: Low↳ subsidiary of DSS, INC.

Canonical registry

IMPACT BIOMEDICAL INC.

ent_019fa203496328b6bfc2790f843c7282

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: IMPACT BIOMEDICAL INC.
Normalized: impact biomedical— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001834105
Domain: None on record
Corporate parent: DSS, INC.— per SEC Exhibit 21 filing

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-03-11
SEC 10-K Item 1C filing describing the company's cybersecurity risk management strategy, governance, and controls. The company utilizes a Microsoft cloud ecosystem and a third-party cybersecurity provider. No specific cybersecurity incident, breach, or material impact is disclosed in this text.